Assessment Builder
AI-assisted ABA assessment reporting software for BCBAs
Software · Cloud SaaSCompany source
Company profile
About Frontera
Frontera Health is a healthcare AI company revolutionizing early intervention care for children with autism and related developmental disorders. The company develops AI-assisted clinical documentation tools specifically designed for Applied Behavior Analysis (ABA) practitioners and clinical psychologists. Their flagship products include Assessment Builder, which helps BCBAs create comprehensive treatment plans and assessment reports in 2-3 hours instead of 6-10 hours, and Diagnosis Builder, which enables clinicians to produce insurance-ready diagnostic reports in half the typical time. The platform leverages advanced AI to analyze unstructured data from clinical notes, intake forms, video recordings, and voice data through what they call 'digital phenotyping.' Frontera's technology is built on proprietary prompt engineering frameworks developed with clinical experts and validated in real-world settings at their owned and operated ABA clinics across rural New Mexico. The company's mission centers on addressing the critical shortage of behavioral health specialists and reducing waitlists that can exceed one year, particularly in underserved rural areas. By streamlining clinical documentation, Frontera enables providers to see more patients, reduce burnout, and accelerate time to treatment for children who need early intervention. Their platform integrates with existing practice management systems and maintains strict HIPAA compliance and data security standards.
Company description Frontera official website
Primary marketClinical Documentation & Workflow
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Frontera?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Autism Spectrum Disorder
- Behavioral health challenges
- Developmental disorders
- Learning disabilities
Who it serves
- ABA clinics
- ABA practitioners
- Autism assessment specialists
- BCBAs (Board Certified Behavior Analysts)
- Behavioral health practices
- Clinical psychologists
Deployment & integration
Cloud Saas deployment with recorded integration context.
Recorded integration context: Various practice management systems (specific names not mentioned).
Geographic context
MarketsRural New Mexico (owned clinics in Clovis, Hobbs, Las Cruces, Roswell, Santa Teresa, Alamogordo) · United States
Company sourceOfficial website
Company milestones
Platform expansion
Operating owned and operated ABA clinics across six locations in rural New Mexico where technology is validated
Partnerships
Recorded partners
No partners are currently listed.
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Diagnosis Builder
AI-assisted diagnosis report builder for clinicians
Software · Cloud SaaSCompany source
Digital Phenotyping
Revolutionary therapy video analysis & advanced behavioral insights
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
A protocol for ploidy determination in ethanol-fixed Atlantic salmon (Salmo salar) fry using propidium iodide and internal standardization: Compatible with field conditions at the sample preservation stage.MethodsX · Dec 1, 2026
Antifungal action of menthol and menthone against Botrytis cinerea: Physiological responses associated with membrane integrity, mitochondrial activity, and oxidative stress, and lipid nanoparticle formulation for its application.Microbiological research · Dec 1, 2026
Corrigendum to "Sex and age differences in alcohol-attributable mortality in Chile between 2008 and 2022" [Public Health Pract. (2026) 100798].Public health in practice (Oxford, England) · Dec 1, 2026
High-resolution X-ray fluorescence imaging of silver-based contrast agents by EDXRF spectrometry: A preclinical study.Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine · Nov 1, 2026
Vaccinium meridionale Swartz (Agraz): A systematic review of phytochemical composition, extraction technologies, and biological effects.Food research international (Ottawa, Ont.) · Oct 31, 2026
Multilevel drivers and constraints of shifts from injecting to smoking opioids and stimulants: A qualitative study from the San Diego-Tijuana border region.Drug and alcohol dependence · Oct 1, 2026
Clinical validation
Clinical-trial records
Nutritional Intervention for Older Adults With Complete DenturesNCT07692828 · Sponsor · RECRUITING
Mama Empoderada: Adapting a Novel Mental Health Prevention Intervention for Migrant Mothers With Young ChildrenNCT06468046 · Sponsor · COMPLETED
Adduction and Infraspinatus Activity in Shoulder PainNCT07765056 · Sponsor · COMPLETED
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD MutationsNCT07195695 · Mentioned · RECRUITING
Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC PatientsNCT07242547 · Mentioned · RECRUITING
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT07222566 · Mentioned · RECRUITING
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Documentation time reduction from 6-10 hours to 2-3 hours
Assessment report writing for BCBAs
50% reduction in documentation time
Evaluation process for autism assessment specialists
Diagnostic report completion in half the time
Clinical psychologists producing insurance-ready reports
Caitlin Young, M.S., BCBA, LBA
Reducing time spent on treatment plan documentation to allow more time for patient and family interactions
Assessment Builder has been a game-changer, allowing clinician to focus on building relationships while the tool captures essential details
Erin Crawford - EmpowerED Psychological Services
Reducing time spent on assessment report writing
Significantly reduced the amount of time spent on report writing, allowing more time working with students
Haley Golden - AT4K
Reducing documentation time during the evaluation process
Less than 50% of the time spent crafting well-formulated notes that meet the needs of providers, families, and payors
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Amol Deshpande
Founder
06 · Company updates
Updates from Frontera
Recent articles published on Frontera's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Clinical Documentation & Workflow
Companies that use AI to automate clinical documentation, generate medical notes from patient-clinician conversations, or streamline clinical workflows. Includes ambient AI scribes, voice-to-text medical documentation, NLP-powered clinical note generation, and tools that reduce administrative burden on clinicians.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.